Article
Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Clinical pharmacology and therapeutics - 1 Dec 2005
Landau Ruth, Morales Michel A, Antonarakis Stylianos E, Blouin Jean-Louis, Smiley Richard M
Abstract excerpt
BACKGROUND: Beta(2)-adrenergic receptor (beta(2)AR) agonists are not consistently successful when administered as tocolytic therapy. The beta(2)AR displays genetic variability; an arginine-to-glycine substitution at codon 16 (Arg16Gly) has been shown to increase receptor desensitization in respon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
